Abstract
The preparation and characterization of the new mononuclear complexes [Rh(C5Me5)Cl2(pydz)], [Rh(C5Me5)Cl(pydz)2][X], and [Rh(C5Me5)(acac)(pydz)][X](pydz = pyridazine, X = BF4 or ClO4, acac = acetylacetonate) are reported. The mononuclear complex [Rh(C5Me5)Cl2(pydz)] reacts with the solvated species [Rh(C5Me5)L3][X]2(L = acetone) to form [{Rh(C5Me5)}2(µ-Cl)2(µ-pydz)][X]2. The structure of the latter complex (X = ClO4) has been determined by X-ray diffraction methods. Crystals are monoclinic, space group P21/n with Z= 4 in a unit cell of dimensions a= 22.2761(9), b= 7.940 7(1), c= 19.359 5(8)A, and β= 109.824(3)°. The structure was solved by Patterson analysis and refined by full-matrix least-squares methods to R= 0.047 for 3 970 observed reflections. The cation consists of two Rh(C5Me5) moieties triply bridged by two chlorine atoms and a pyridazine group. The latter co-ordinates in an exo-bidentate manner through the two nitrogen atoms. The two rhodium atoms are separated by 3.397(1)A. Attempts to isolate homovalent double-bridged complexes of general formula [Rh2(C5Me5)2Cl2(pydz)2]2+ or mixed-valence rhodium(III)-rhodium(I) complexes of formulae [(C5Me5)ClRh(µ-Cl)(µ-pydz)Rh(tfb)]+ or [(C5Me5)ClRh(µ-pydz)2Rh(tfb)]2+(tfb = 5,6,7,8-tetrafluoro-1,4-dihydro-1,4-ethenonaphthalene) have been unsuccessful.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have